Mounjaro 10mg Online: What the Clinical Evidence Tells You

Fourth in the licensed sequence: Mounjaro 10mg follows the 2.5mg, 5mg and 7.5mg steps; the prescriber decides when (and whether) a dose increase is appropriate.
Dual-receptor action: tirzepatide activates both GIP and GLP-1 receptors, the only weight-loss medicine licensed in the UK to do so, reducing appetite and slowing gastric emptying.
Trial evidence: in SURMOUNT-1, participants on 10mg achieved average body-weight reductions in the region of 19–20% over 72 weeks, with the 15mg arm extending that to around 21%.
Black Triangle medicine (▼): Mounjaro carries additional MHRA monitoring; any suspected side effects can be reported at yellowcard.mhra.gov.uk.

Mounjaro 10mg is the fourth dose step in the licensed tirzepatide schedule, and trial data from the SURMOUNT programme show it produces meaningful weight reduction in most adults who reach it. Like every strength of Mounjaro, the 10mg pen is a prescription-only medicine — a prescriber assesses whether it is the right next step for you before it can be dispensed. This page explains what the evidence says about this specific dose, who typically reaches it, and what to expect when you do.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The Evidence, the Dose Step and What Patients Need to Know About Mounjaro 10mg

What SURMOUNT-1 shows at the 10mg dose — and why it matters

The clearest picture of Mounjaro 10mg in clinical practice comes from SURMOUNT-1, published in the New England Journal of Medicine, a 72-week randomised trial involving 2,539 adults with obesity but without type 2 diabetes. Participants were assigned to 5mg, 10mg or 15mg tirzepatide alongside lifestyle support, or to placebo. The 10mg group achieved average body-weight reductions in the region of 19–20%, a result that would have been considered remarkable for any single medicine just a few years ago.

What that figure tells us is that the 10mg dose is genuinely therapeutic in its own right, not simply a staging post. Some people respond very well at this level and their prescriber may judge there is no clinical need to increase further. Others titrate on to 12.5mg or 15mg depending on tolerability and response. The decision belongs to the prescriber, not the dose ladder itself.

It is also worth understanding the trial's structure: participants began at 2.5mg and increased every four weeks, so the 10mg results reflect a population that had already spent three months at lower doses letting their bodies adjust. That staged approach is central to why gastrointestinal side effects, while common, are usually manageable rather than severe for most people. The NHS tirzepatide page summarises both the expected effects and the warning signs to watch for.

How 10mg fits into the full Mounjaro dose schedule

A question our prescribers hear most weeks is whether a patient can start at 10mg to get results faster. The short answer is no, and the reason is clinical, not administrative. The 2.5mg starting dose exists to let the body adapt to tirzepatide's effects on gastric emptying and gut signalling; jumping to a higher dose significantly increases the likelihood of nausea, vomiting and diarrhoea severe enough to interrupt treatment entirely.

The licensed UK sequence runs 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg, with each step held for a minimum of four weeks. Reaching 10mg typically means you are around 14–16 weeks into treatment. Some people move more slowly if a lower dose is working well or if a step caused side effects that needed more time to settle. If you want to understand how the 5mg experience generally compares, our Mounjaro 5mg page covers what the evidence shows at that earlier stage.

Dose increases require clinical review at nume, evidence of your current dose and weight trend is assessed before any change is authorised. That applies whether you are transferring from another provider or progressing through the schedule with us. No increase is automatic.

Side effects that tend to become more noticeable at 10mg

Moving from 7.5mg to 10mg is the dose step where some patients notice a return of the gastrointestinal symptoms they thought had settled, particularly nausea, loose stools or a sharper reduction in appetite. This is well-documented in clinical data and usually resolves within one to two weeks as the body adjusts to the higher exposure.

The side-effect profile at 10mg is broadly the same as earlier steps: nausea, vomiting, diarrhoea, constipation, indigestion, fatigue and injection-site reactions are the most commonly reported. Serious effects are uncommon but not unknown. Acute pancreatitis is a known infrequent risk across GLP-1 medicines; the MHRA highlighted this in a January 2026 Drug Safety Update. Severe, persistent stomach pain (particularly if it radiates toward the back) is the symptom to act on quickly. You should stop the injection and seek medical help, not wait for the next scheduled review.

For a more detailed breakdown of what to expect at the dose that immediately precedes 10mg, the 7.5mg side-effects page runs through the pattern in full. Practical questions about how the 10mg pen itself is used (including how many clicks make up a full dose) are answered on our 10mg pen clicks page.

Getting Mounjaro 10mg through a regulated UK pharmacy

Mounjaro at any strength can only be legally supplied following a valid prescription issued after a clinical assessment. There is no route to obtaining it otherwise. That means if you see it offered online without any form of clinical consultation, you are looking at an unregulated seller, and, following large-scale MHRA enforcement action through 2025, potentially a counterfeit product.

The safe route is a GPhC-registered pharmacy where a qualified prescriber reviews your consultation. You can verify any online pharmacy on the GPhC pharmacy register; it takes about thirty seconds. If a pharmacy is not listed, do not use it for prescription medicines.

Cost is a real consideration for many people, and it is worth understanding what legitimate pricing actually includes before comparing headline figures. Our Mounjaro price comparison page sets out what the UK market looks like and what to look for beyond the per-pen figure. At nume, the consultation, prescription, clinical review and next-working-day delivery are all included, there are no hidden charges and no subscription.

If you are already familiar with how the 10mg pen works physically and want the specific volume information, our 10mg Mounjaro in ml page covers that clearly. And if you want to understand the weight-loss results evidence specific to this dose step in more depth, our 10mg weight loss results page goes further into the SURMOUNT data.

If you are ready to discuss whether tirzepatide is appropriate for you, start your free consultation and a GPhC-registered prescriber at nume will review it the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions